|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 105, Issue 1 191-201, Copyright © 1993 by Company of Biologists
JOURNAL ARTICLES |
L Thomas, PW Chan, S Chang and C Damsky
Department of Anatomy, School of Dentistry, University of California San Francisco 94143-0512.
Cell interactions with the extracellular matrix play a critical role in regulating complex processes such as terminal differentiation and tumor progression. In these studies we describe a melanoma cell system that should be useful in addressing the regulation of cell-matrix interactions and the roles they play in regulating differentiation and cell invasiveness. CS (suspension)-1 melanoma cells are relatively well differentiated: they are melanotic, responsive to melanocyte-stimulating hormone, and express TA99, a melanosome membrane differentiation marker. Their repertoire of integrin receptors for extracellular matrix ligands is limited; in particular, they lack receptors for vitronectin, accounting for the observation that they are nonadherent when cultured in the presence of serum. CS-1 cells are noninvasive as well, and express low levels of both metalloproteinases and activated plasminogen activators. Treatment of these cells with melanocyte-stimulating hormone causes them to increase melanin production and assume an arborized phenotype, suggesting that it promotes their further differentiation. In contrast, treatment of CS-1 with the thymidine analog 5-bromodeoxyuridine, converts them to a highly invasive cell population (termed BCS-1) that loses its differentiated properties and responsiveness to melanocyte-stimulating hormone, acquires a broad integrin repertoire (including vitronectin receptors), and expresses elevated levels of metalloproteinases and activated urokinase. From these observations and findings of others on BrdU treatment of other developmental lineages, we hypothesize that BrdU both suppresses differentiation and promotes invasiveness of CS-1 cells. The demonstrated manipulability of CS-1 cells should make them extremely useful for studying the regulation of both terminal differentiation and tumor progression in the melanocyte lineage.
This article has been cited by other articles:
|
|
 |
|
  G. R. Medigeshi, A. J. Hirsch, D. N. Streblow, J. Nikolich-Zugich, and J. A. Nelson West Nile Virus Entry Requires Cholesterol-Rich Membrane Microdomains and Is Independent of {alpha}v{beta}3 Integrin J. Virol., June 1, 2008; 82(11): 5212 - 5219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Hu and S. M. Strittmatter The N-Terminal Domain of Nogo-A Inhibits Cell Adhesion and Axonal Outgrowth by an Integrin-Specific Mechanism J. Neurosci., January 30, 2008; 28(5): 1262 - 1269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Asokan, J. B. Hamra, L. Govindasamy, M. Agbandje-McKenna, and R. J. Samulski Adeno-Associated Virus Type 2 Contains an Integrin {alpha}5{beta}1 Binding Domain Essential for Viral Cell Entry. J. Virol., September 1, 2006; 80(18): 8961 - 8969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cluzel, F. Saltel, J. Lussi, F. Paulhe, B. A. Imhof, and B. Wehrle-Haller The mechanisms and dynamics of {alpha}v{beta}3 integrin clustering in living cells J. Cell Biol., October 24, 2005; 171(2): 383 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wu, S. Singh, M.-M. Georgescu, and R. B. Birge A role for Mer tyrosine kinase in {alpha}v{beta}5 integrin-mediated phagocytosis of apoptotic cells J. Cell Sci., February 1, 2005; 118(3): 539 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R Elshaw, K. Sisley, N. Cross, A. K Murray, S. M MacNeil, M. Wagner, C. E Nichols, and I. G Rennie A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of {alpha}1{beta}1, {alpha}4{beta}1 and {alpha}6{beta}1 integrins Br. J. Ophthalmol., June 1, 2001; 85(6): 732 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Soudais, S. Boutin, S. S. Hong, M. Chillon, O. Danos, J. M. Bergelson, P. Boulanger, and E. J. Kremer Canine Adenovirus Type 2 Attachment and Internalization: Coxsackievirus-Adenovirus Receptor, Alternative Receptors, and an RGD-Independent Pathway J. Virol., November 15, 2000; 74(22): 10639 - 10649. [Abstract] [Full Text]
|
|
|
|
|
|
K. Wang, T. Guan, D. A. Cheresh, and G. R. Nemerow Regulation of Adenovirus Membrane Penetration by the Cytoplasmic Tail of Integrin beta 5 J. Virol., March 15, 2000; 74(6): 2731 - 2739. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Jecker, A. Beuleke, I. Dressendorfer, R. Pabst, and J. Westermann Long-term Oral Application of 5-Bromo-2-Deoxyuridine Does Not Reliably Label Proliferating Immune Cells in the LEW Rat J. Histochem. Cytochem., March 1, 1997; 45(3): 393 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Filardo, S. Deming, and D. Cheresh Regulation of cell migration by the integrin beta subunit ectodomain J. Cell Sci., January 6, 1996; 109(6): 1615 - 1622. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Pfeifer, T. Kessler, S. Silletti, D. A. Cheresh, and I. M. Verma Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2 PNAS, October 24, 2000; 97(22): 12227 - 12232. [Abstract] [Full Text] [PDF]
|
|
